The World Health Organization reference reagent for vascular endothelial growth factor, VEGF165 TECHNICAL NOTE

CJ Robinson, R Gaines Das, R Stammers… - Growth …, 2006 - Taylor & Francis
CJ Robinson, R Gaines Das, R Stammers, B Rafferty
Growth Factors, 2006Taylor & Francis
Preparations of human sequence recombinant vascular endothelial growth factor-165
(VEGF165) synthesized in Escherichia coli were formulated and lyophilized at NIBSC.
Following evaluation at NIBSC, the first preparation, 01/424, has been distributed since
2002 as a NIBSC research reagent, but shows variation between ampoules in the volume
and crystalline appearance of the lyophilized plug. A second preparation, 02/286, was
subsequently lyophilized in a different formulation. Preparation 02/286 has now been …
Preparations of human sequence recombinant vascular endothelial growth factor-165 (VEGF165) synthesized in Escherichia coli were formulated and lyophilized at NIBSC. Following evaluation at NIBSC, the first preparation, 01/424, has been distributed since 2002 as a NIBSC research reagent, but shows variation between ampoules in the volume and crystalline appearance of the lyophilized plug. A second preparation, 02/286, was subsequently lyophilized in a different formulation. Preparation 02/286 has now been evaluated in a collaborative study for its suitability to serve as a reference standard, and compared with preparation 01/424, by five laboratories using in vitro bioassays or immunoassays. On the basis of the results reported here, the World Health Organization (WHO) established the preparation coded 02/286 as the WHO reference reagent (RR) for human VEGF165, with an assigned unitage of 13,000 units per ampoule. Details on ordering the WHO RR can be found at www.nibsc.ac.uk.
Taylor & Francis Online